1. Home
  2. MDXG vs DK Comparison

MDXG vs DK Comparison

Compare MDXG & DK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • DK
  • Stock Information
  • Founded
  • MDXG 2006
  • DK 2001
  • Country
  • MDXG United States
  • DK United States
  • Employees
  • MDXG N/A
  • DK N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • DK Integrated oil Companies
  • Sector
  • MDXG Health Care
  • DK Energy
  • Exchange
  • MDXG Nasdaq
  • DK Nasdaq
  • Market Cap
  • MDXG 1.0B
  • DK 1.0B
  • IPO Year
  • MDXG N/A
  • DK 2006
  • Fundamental
  • Price
  • MDXG $7.05
  • DK $15.36
  • Analyst Decision
  • MDXG Strong Buy
  • DK Hold
  • Analyst Count
  • MDXG 3
  • DK 12
  • Target Price
  • MDXG $12.00
  • DK $16.75
  • AVG Volume (30 Days)
  • MDXG 812.0K
  • DK 1.4M
  • Earning Date
  • MDXG 04-30-2025
  • DK 05-07-2025
  • Dividend Yield
  • MDXG N/A
  • DK 6.69%
  • EPS Growth
  • MDXG N/A
  • DK N/A
  • EPS
  • MDXG 0.27
  • DK N/A
  • Revenue
  • MDXG $352,375,000.00
  • DK $11,366,100,000.00
  • Revenue This Year
  • MDXG $9.23
  • DK N/A
  • Revenue Next Year
  • MDXG $11.49
  • DK N/A
  • P/E Ratio
  • MDXG $26.15
  • DK N/A
  • Revenue Growth
  • MDXG 5.34
  • DK N/A
  • 52 Week Low
  • MDXG $5.47
  • DK $11.03
  • 52 Week High
  • MDXG $10.14
  • DK $29.14
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 51.34
  • DK 63.57
  • Support Level
  • MDXG $6.53
  • DK $13.29
  • Resistance Level
  • MDXG $7.07
  • DK $14.08
  • Average True Range (ATR)
  • MDXG 0.33
  • DK 0.70
  • MACD
  • MDXG 0.10
  • DK 0.34
  • Stochastic Oscillator
  • MDXG 68.03
  • DK 89.98

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. Delek's logistics segment sells portions of the petroleum products its refineries produce. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

Share on Social Networks: